(Q44824771)

English

Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil-cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck

scientific article published in April 2004

In more languages
default for all languages
No label defined

No description defined

Statements

Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil-cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck (English)
Adriano Paccagnella
Christian Domenge

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit